This week's Fierce Drug Delivery is brought to you by Catalent.

Are larger molecules and novel indications the future of Orally Inhaled & Nasal Drug Delivery?

Hi E, check out this complimentary eBook we think you'll like:

Catalent’s Carla Vozone discusses the significant trends in the Orally Inhaled & Nasal Drug Delivery (OINDP) segment including larger molecules and novel indications. She also discusses changes within CDMOs and various challenges facing the industry. Learn more about:

• Trends in orally and nasally inhaled therapeutics

• New avenues for existing dose forms

• Industry response to OINDP trends.